Edgewise Therapeutics, Inc. (EWTX) Financials
EWTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 518.5 million | 25.3 million |
| Dec. 31, 2025 | 552.6 million | 30.3 million |
| Sept. 30, 2025 | 583.5 million | 24.8 million |
| June 30, 2025 | 613.3 million | 24.3 million |
EWTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -42.8 million | ? |
| Dec. 31, 2025 | -38.4 million | -24.9 million |
| Sept. 30, 2025 | -34.9 million | 8.1 million |
| June 30, 2025 | -32.6 million | 7.7 million |
EWTX Net Income
No data available :(
EWTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 499.6 million | 2.8 million | - |
| Dec. 31, 2025 | 530.1 million | 3.0 million | 4.0 million |
| Sept. 30, 2025 | 563.3 million | 3.2 million | 4.2 million |
| June 30, 2025 | 594.0 million | - | 4.4 million |
EWTX Shares Outstanding
EWTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 260000 | 42.7 million | 11.5 million | - |
| Dec. 31, 2025 | 183000 | 43.6 million | 12.4 million | - |
| Sept. 30, 2025 | 89000 | 37.5 million | 9.4 million | - |
| June 30, 2025 | 50000 | 33.6 million | 9.1 million | - |
EWTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 590000 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 567000 |
EWTX
Price: $35.21
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 74985
Market Capitalization: 4.0 billion